Victor Olmos
Associate Kendall Capital Partners
Seminars
Tuesday 27th January 2026
Bridging Stakeholders in Aging Therapeutics: Overcoming Translational Challenges, Aligning Investors & Regulators, & Driving Cross-Sector Innovation to Accelerate Therapy Development
1:30 pm
- 4:30 pm
The development of aging therapeutics requires unprecedented collaboration across investors, regulators, pharma, and biotech leaders. Long timelines, complex endpoints, and regulatory uncertainty create significant hurdles to advancing safe, effective, and commercially viable drugs. Aligning early on regulatory frameworks, validating biomarkers, mitigating risks, and fostering partnerships will be critical to accelerating
progress in this space.
In this 3-hour workshop, we will explore strategies to overcome translational bottlenecks and build stronger cross-sector alignment:
- Navigating uncertain returns during long timelines to meet demands for clearer early efficacy markers in aging drug portfolios
- Balancing rigorous safety standards with flexible frameworks to accommodate novel aging biomarkers and functional endpoints
- Overcoming challenges in patient recruitment and endpoint validation through digital health and real-world data integration
- Addressing funding constraints and translational bottlenecks to strategically align with investors and regulatory bodies early on
